Philip Homan
-
- RNA and protein synthesis mechanisms 5
- RNA modifications and cancer 4
-
- Immune Cell Function and Interaction 2
- Immune cells in cancer 2
- T-cell and Retrovirus Studies 1
-
- Cancer Immunotherapy and Biomarkers 2
-
- Virus-based gene therapy research 1
-
- SARS-CoV-2 and COVID-19 Research 1
- Co-authors
- Kevin M. WeeksNikolay V. DokholyanOleg V. FavorovOlcay KurşunChristopher A. LavenderSteven BusanXi‐Yuan GeAlison G. Smith
- Cited by
- Molecular BiologyImmunologyOncology
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Nature Communications (2 papers)The Journal of Experimental Medicine (1 paper)
- Partner nations
- United StatesJapanAustralia
In The Last Decade
Philip Homan
13 papers receiving 392 citations
Peers
Comparison fields: 5 of 62
- Molecular Biology 304
- Immunology 69
- Oncology 52
- Cancer Research 20
- Genetics 36
Countries citing papers authored by Philip Homan
This map shows the geographic impact of Philip Homan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Homan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Homan more than expected).
Fields of papers citing papers by Philip Homan
This network shows the impact of papers produced by Philip Homan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Homan. The network helps show where Philip Homan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Philip Homan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 4 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 46 | |
| 5 | 2023 | 9 | |
| 6 | 2022 | 3 | |
| 7 | 2022 | 11 | |
| 8 | 2021 | 35 | |
| 9 | 2017 | 22 | |
| 10 | 2017 | 12 | |
| 11 | 2015 | 33 | |
| 12 | 2014 | 135 | |
| 13 | 2014 | 72 | |
| 14 | 2014 | 14 |
About Philip Homan
Philip Homan is a scholar working on Immunology, Oncology and Immunology and Allergy, having authored 14 papers that have together received 397 indexed citations. Recurring topics across this work include RNA and protein synthesis mechanisms (5 papers), RNA modifications and cancer (4 papers), Immune Cell Function and Interaction (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Immune cells in cancer (2 papers), SARS-CoV-2 and COVID-19 Research (1 paper), Virus-based gene therapy research (1 paper) and T-cell and Retrovirus Studies (1 paper). The work is most often cited by research in Molecular Biology (304 citations), Immunology (69 citations) and Oncology (52 citations). Philip Homan has collaborated with scholars based in United States, Japan and Australia. Frequent co-authors include Kevin M. Weeks, Nikolay V. Dokholyan, Oleg V. Favorov, Olcay Kurşun, Christopher A. Lavender, Steven Busan, Xi‐Yuan Ge, Alison G. Smith, A.R. Ferré-D′Amaré and K.D. Warner. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.